SPRY4 and Kallmann syndrome: Since the phenotype characteristics of Kallmann syndrome suggest that an associated causative change of a sequence would result in reduced FGF-mediated signaling and Spry4 is a well-known inhibitor of the downstream MAPK pathway, we first compared mutated SpryY241 with the wildtype Spry4S241 concerning their influence on this pathway.